<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-046476</identifier>
<setSpec>0212-6982</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Role of bone gammagraphy in the diagnosis of osteomalacy secondary to tenofovir treatment</dc:title>
<dc:description xml:lang="en">It is reported a HIV infected patient under antiretroviral therapy including tenofovir therapy who was referred to the Nuclear Medicine Department to complete bone pain study. A bone scan was performed at 3 hours after the injection of 740 MBq of 99mTc-MDP, revealing an abnormal distribution with characteristic changes compatible with osteomalacia. In further analysis, a secondary hyperparathyroidism and osteomalacia were diagnosed in the context of Fanconi syndrome, an infrequent complication described in patients under treatment with tenofovir</dc:description>
<dc:creator>Val Gómez Martínez, M. del</dc:creator>
<dc:creator>Gambí Pisonero, N</dc:creator>
<dc:creator>Torres Isidro, M</dc:creator>
<dc:creator>González-Lahoz, J</dc:creator>
<dc:creator>González Gallardo, F</dc:creator>
<dc:creator>Castilla Miguel, S</dc:creator>
<dc:creator>García Benayas, T</dc:creator>
<dc:creator>Gallego Sanz, D</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Presentamos el caso clínico de un paciente infectado por el virus de la inmunodeficiencia humana (VIH) que recibía tratamiento antirretrovírico, incluyendo el análogo de nucleótido tenofovir, y que acudió al servicio de Medicina Nuclear para completar un estudio por dolor óseo. En la gammagrafía ósea, realizada a las tres horas de la administración de 740 MBq de 99mTc-MDP, se observó un patrón anómalo de captación del trazador, con características compatibles con osteomalacia. En estudios analíticos realizados con posterioridad fue diagnosticado de osteomalacia e hiperparatiroidismo secundario a síndrome de Fanconi, que es una complicación infrecuente descrita en los pacientes tratados con tenofovir</dc:description>
<dc:source>Rev Esp Med Nucl;25(2): 103-106, mar. 2006. ilus</dc:source>
<dc:identifier>ibc-046476</dc:identifier>
<dc:title xml:lang="es">Utilidad de la gammagrafía ósea en el diagnóstico de osteomalacia secundaria en un paciente en tratamiento con tenofovir</dc:title>
<dc:subject>^d24718^s22057</dc:subject>
<dc:subject>^d471^s22062</dc:subject>
<dc:subject>^d33075^s22073</dc:subject>
<dc:subject>^d233^s22020</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d233^s22000</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d233^s22073</dc:subject>
<dc:subject>^d7141^s22036</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d35395</dc:subject>
<dc:subject>^d5302^s22036</dc:subject>
<dc:subject>^d10198^s22008</dc:subject>
<dc:subject>^d233^s22003</dc:subject>
<dc:subject>^d7141^s22008</dc:subject>
<dc:subject>^d11184^s22073</dc:subject>
<dc:subject>^d33075^s22020</dc:subject>
<dc:subject>^d11184^s22020</dc:subject>
<dc:subject>^d33075^s22000</dc:subject>
<dc:subject>^d5302^s22062</dc:subject>
<dc:subject>^d11184^s22000</dc:subject>
<dc:subject>^d10198^s22036</dc:subject>
<dc:type>article</dc:type>
<dc:date>200603</dc:date>
</metadata>
</record>
</ibecs-document>
